Elevated levels of GluR1 in the midbrain: A trigger for sensitization to drugs of abuse?

Trends in Neurosciences

Volumn 25, Issue 12, 2002, Pages 610-615

  Carlezon Jr, William A ^a   Nestler, EricJ ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPA RECEPTOR; AMPHETAMINE; COCAINE; DOPAMINE; GLUTAMATE RECEPTOR; MORPHINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NICOTINE; RECEPTOR SUBTYPE;

ADAPTATION; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG RESPONSE; MESENCEPHALON; MOLECULE; NERVE CELL; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REACTOR CASCADE; REVIEW; SENSITIZATION; VENTRAL TEGMENTUM;

ANIMALS; RECEPTORS, AMPA; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; VENTRAL TEGMENTAL AREA;

EID: 0036890466     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(02)02289-0     Document Type: Review

References (70)

1. Babbini M., Davis W.M. Time-dose relationships for locomotor activity effects of morphine after acute or repeated treatment. Br. J. Pharmacol. 46:1972;213-224.
2. Post R.M., Rose H. Increasing effects of repetitive cocaine administration in the rat. Nature. 260:1976;731-732.
3. Segal D.S., Mandell A.J. Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy. Pharmacol. Biochem. Behav. 2:1974;249-255.
4. Shoaib M., Stolerman I.P. MK801 attenuates behavioural adaptation to chronic nicotine administration in rats. Br. J. Pharmacol. 105:1992;514-515.
5. Nabeshima T., et al. Development of tolerance and supersensitivity to phencyclidine in rats after repeated administration of phencyclidine. Eur. J. Pharmacol. 135:1987;23-33.
6. Broadbent J., et al. Haloperidol prevents ethanol-stimulated locomotor activity but fails to block sensitization. Psychopharmacology (Berl.). 120:1995;475-482.
7. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. 396:1986;157-198.
8. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Brain Res. Rev. 16:1991;223-244.
9. Wolf M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54:1998;679-720.
10. Lett B.T. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology (Berl.). 98:1989;357-362.
11. Piazza P.V., et al. Factors that predict individual vulnerability to amphetamine self-administration. Science. 245:1989;1511-1513.
12. Robinson T.E., Berridge K.C. The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction. 95:(Suppl 2):2000;S91-S117.
13. Vezina P., Stewart J. The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. Brain Res. 499:1989;108-120.
14. Vezina P. D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area. J. Neurosci. 16:1996;2411-2420.
15. Pollock J., Kornetsky C. Evidence for the role of dopamine D1 receptors in morphine induced stereotypic behavior. Neurosci. Lett. 102:1989;291-296.
16. Shippenberg T.S., Heidbreder C. Sensitization to the conditioned rewarding effects of cocaine: pharmacological and temporal characteristics. J. Pharmacol. Exp. Ther. 273:1995;808-815.
17. Kita T., et al. Nicotine-induced sensitization to ambulatory stimulant effect produced by daily administration into the ventral tegmental area and the nucleus accumbens in rats. Life Sci. 50:1992;583-590.
18. Jeziorski M., White F.J. Dopamine receptor antagonists prevent expression, but not development, of morphine sensitization. Eur. J. Pharmacol. 275:1995;235-244.
19. Mattingly B.A., et al. Cocaine-induced behavioral sensitization: effects of haloperidol and SCH 23390 treatments. Pharmacol. Biochem. Behav. 53:1996;481-486.
20. Carlezon W.A. Jr, et al. AMPA antagonist LY293558 blocks the development, without blocking the expression, of behavioral sensitization to morphine. Synapse. 31:1999;56-262.
21. Ranaldi R., et al. Morphine and amphetamine sensitization in rats demonstrated under moderate- and high-dose NMDA receptor blockade with MK-801 (dizocilpine). Psychopharmacology (Berl.). 151:2000;192-201.
22. Carlezon W.A. Jr, et al. Behavioral interactions caused by combined administration of morphine and MK-801 in rats. Psychopharmacology (Berl.). 151:2000;261-272.
23. Kalivas P.W., Weber B. Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine. J. Pharmacol. Exp. Ther. 245:1988;1095-1102.
24. Vezina P., Stewart J. Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects. Brain Res. 516:1990;99-106.
25. Perugini M., Vezina P. Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine. J. Pharmacol. Exp. Ther. 270:1994;690-696.
26. Cador M., et al. Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience. 65:1995;385-395.
27. Cornish J.L., Kalivas P.W. Repeated cocaine administration into the rat ventral tegmental area produces behavioral sensitization to a systemic cocaine challenge. Behav. Brain Res. 126:2001;205-209.
28. Stewart J., Vezina P. Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine. Brain Res. 495:1989;401-406.
29. Kalivas P.W., Alesdatter J.E. Involvement of n-methyl-d-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 267:1993;486-495.
30. Carr D.B., Sesack S.R. Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J. Neurosci. 20:2000;3864-3873.
31. Lokwan S.J., et al. The medial prefrontal cortex plays an important role in the excitation of A10 dopaminergic neurons following intravenous muscimol administration. Neuroscience. 95:2000;647-656.
32. Cornwall J., et al. Afferent and efferent connections of the laterodorsal tegmental nucleus in the rat. Brain Res. Bull. 25:1990;271-284.
33. Henry D.J., White F.J. The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons. J. Neurosci. 15:1995;6287-6299.
34. Churchill L., et al. Repeated cocaine alters glutamate receptor subunit levels in the nucleus accumbens and ventral tegmental area of rats that develop behavioral sensitization. J. Neurochem. 72:1999;2397-2403.
35. Thomas M.J., et al. Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine. Nat. Neurosci. 4:2001;1217-1223.
36. Todtenkopf M.S., et al. Neither ibotenic acid nor volkensin lesions of the nucleus accumbens shell affect the expression of cocaine sensitization. Eur. J. Neurosci. 16:2002;541-546.
37. Beitner-Johnson D., Nestler E.J. Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions. J. Neurochem. 57:1991;344-347.
38. Beitner-Johnson D., et al. Neurofilament proteins and the mesolimbic dopamine system: common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area. J. Neurosci. 12:1992;2165-2176.
39. Ortiz J., et al. Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system. Synapse. 21:1995;289-298.
40. Fitzgerald L.W., et al. Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. J. Neurosci. 16:1996;274-282.
41. Lu W., et al. Repeated administration of amphetamine or cocaine does not alter AMPA receptor subunit expression in the rat midbrain. Neuropsychopharmacology. 26:2001;1-13.
42. Hollmann M., Heinemann S. Cloned glutamate receptors. Annu. Rev. Neurosci. 17:1994;31-108.
43. Carlezon W.A. Jr, et al. Sensitization to morphine induced by viral-mediated gene transfer. Science. 277:1997;812-814.
44. Neve R.L., et al. Introduction of the glutamate receptor subunit 1 into motor neurons in vitro and in vivo using a recombinant herpes simplex virus. Neuroscience. 79:1997;435-447.
45. 2+-stimulated adenylyl cyclases in LTP and memory formation. Int. J. Dev. Neurosci. 19:2001;387-394.
46. Zhang X.F., et al. Increased responsiveness of ventral tegmental area dopamine neurons to glutamate after repeated administration of cocaine or amphetamine is transient and selectively involves AMPA receptors. J. Pharmacol. Exp. Ther. 281:1997;699-706.
47. Carlezon W.A. Jr, et al. Distinct sites of opiate reward and aversion within the midbrain identified using a herpes simplex virus vector expressing GluR1. J. Neurosci. 20:2000;1-5.
48. Carlezon W.A. Jr, et al. Downregulation of GluR1 expression in the ventral tegmental area following repeated rewarding brain stimulation. Neuropsychopharmacology. 25:2001;234-241.
49. Frank R.A., et al. The effect of chronic cocaine on self-stimulation train-duration thresholds. Pharmacol. Biochem. Behav. 29:1988;755-758.
50. Bauco P., Wise R.A. Synergistic effects of cocaine with lateral hypothalamic brain stimulation reward: lack of tolerance or sensitization. J. Pharmacol. Exp. Ther. 283:1997;1160-1167.
51. Gilliss B., et al. Cocaine and SKF-82958 potentiate brain stimulation reward in Swiss-Webster mice. Psychopharmacology (Berl.). 163:2002;238-248.
52. Bradberry C.W., Roth R.H. Cocaine increases extracellular dopamine in rat nucleus accumbens and ventral tegmental area as shown by in vivo microdialysis. Neurosci. Lett. 103:1989;97-102.
53. Klitenick M.A., et al. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J. Neurosci. 12:1992;2623-2632.
54. Kalivas P.W., Duffy P. Repeated cocaine administration alters extracellular glutamate in the ventral tegmental area. J. Neurochem. 70:1998;1497-1502.
55. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2:2001;119-128.
56. Malenka R.C., Nicoll R.A. Long-term potentiation-a decade of progress? Science. 285:1999;1870-1874.
57. Ungless M.A., et al. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature. 411:2001;583-587.
58. Tzschentke T.M., Schmidt W.J. Blockade of behavioral sensitization by MK-801: fact or artifact? A review of preclinical data. Psychopharmacology (Berl.). 151:2000;142-151.
59. Sorg B.A., et al. Time course of tyrosine hydroxylase expression after behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 266:1993;424-430.
60. Beitner-Johnson D., Nestler E.J. Chronic morphine impairs axoplasmic transport in the rat mesolimbic dopamine system. Neuroreport. 5:1993;57-60.
61. Parsons L.H., Justice J.B. Jr. Serotonin and dopamine sensitization in the nucleus accumbens, ventral tegmental area, and dorsal raphe nucleus following repeated cocaine administration. J. Neurochem. 61:1993;1611-1619.
62. Karler R., et al. Calcium channel blockers and behavioral sensitization. Life Sci. 49:1991;165-170.
63. Sklair-Tavron L., et al. Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc. Natl. Acad. Sci. U. S. A. 93:1996;11202-11207.
64. Schmidt E.F., et al. Extinction training regulates tyrosine hydroxylase during withdrawal from cocaine self-administration. J. Neurosci. 21:2001;RC137.
65. Parsons L.H., et al. Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine. Synapse. 9:1991;60-65.
66. Segal D.S., Kuczenski R. Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens. Brain Res. 577:1992;351-355.
67. Maisonneuve I.M., et al. Chronic administration of a cocaine 'binge' alters basal extracellular levels in male rats: an in vivo microdialysis study. J. Pharmacol. Exp. Ther. 272:1995;652-657.
68. Ferrari R., et al. Acute and long-term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections. Eur. J. Neurosci. 15:2002;1810-1818.
69. Vanderschuren L.J., Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl.). 151:2000;99-120.
70. Atkins J.B., et al. Region-specific induction of ΔFosB by repeated administration of typical versus atypical antipsychotic drugs. Synapse. 33:1999;118-128.